Terms: = Germ cell tumor AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
22 results:
1. Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study.
Zeng X; Zhang P; Zhu G; Li C; Zhang R; Yu M; Lin G; Di M; Jiang C; Li Y; Sun Y; Xia L; Chi P; Tao K
World J Surg Oncol; 2023 Sep; 21(1):300. PubMed ID: 37736728
[TBL] [Abstract] [Full Text] [Related]
2. Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival prognosis.
Cheng C; Wang D; Yu M; Zhai Y; Pan C; Liang B; Zhang J; Wang C; Yin Y; Li L; Wu F; Shi Z; Fan X; Liu X; Wang Z; Zhao Z; Li G; Jiang T; Zhang W;
Neurosurgery; 2023 Oct; 93(4):802-812. PubMed ID: 37070826
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression.
He X; Feng Y
Anticancer Drugs; 2022 Jun; 33(5):478-488. PubMed ID: 35324527
[TBL] [Abstract] [Full Text] [Related]
4. The Quest for an Accurate Functional tumor Volume with
Reddy RP; Ross Schmidtlein C; Giancipoli RG; Mauguen A; LaFontaine D; Schoder H; Bodei L
J Nucl Med; 2022 Jul; 63(7):1027-1032. PubMed ID: 34772795
[No Abstract] [Full Text] [Related]
5. Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities.
Yan J; Zhao Y; Chen Y; Wang W; Duan W; Wang L; Zhang S; Ding T; Liu L; Sun Q; Pei D; Zhan Y; Zhao H; Sun T; Sun C; Wang W; Liu Z; Hong X; Wang X; Guo Y; Li W; Cheng J; Liu X; Lv X; Li ZC; Zhang Z
EBioMedicine; 2021 Oct; 72():103583. PubMed ID: 34563923
[TBL] [Abstract] [Full Text] [Related]
6. Bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1/5 signaling pathway.
Gao J; Muroya R; Huang F; Nagata K; Shin M; Nagano R; Tajiri Y; Fujii S; Yamaza T; Aoki K; Tamura Y; Inoue M; Chishaki S; Kukita T; Okabe K; Matsuda M; Mori Y; Kiyoshima T; Jimi E
Lab Invest; 2021 Nov; 101(11):1475-1483. PubMed ID: 34504305
[TBL] [Abstract] [Full Text] [Related]
7. A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
Polano M; Fabbiani E; Adreuzzi E; Cintio FD; Bedon L; Gentilini D; Mongiat M; Ius T; Arcicasa M; Skrap M; Dal Bo M; Toffoli G
Cells; 2021 Mar; 10(3):. PubMed ID: 33807997
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors.
Sander MS; Stukalin I; Vallerand IA; Goutam S; Ewanchuk BW; Meyers DE; Pabani A; Morris DG; Heng DYC; Cheng T
Cancer Med; 2021 Apr; 10(8):2618-2626. PubMed ID: 33724676
[TBL] [Abstract] [Full Text] [Related]
9. A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression.
Zhou K; Zhao Z; Li S; Liu Y; Li G; Jiang T
Sci Rep; 2020 Oct; 10(1):18420. PubMed ID: 33116227
[TBL] [Abstract] [Full Text] [Related]
10. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
[TBL] [Abstract] [Full Text] [Related]
11. miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiforme.
Sippl C; Ketter R; Braun L; Teping F; Schoeneberger L; Kim YJ; List M; Nakhoda A; Wemmert S; Oertel J; Urbschat S
Acta Neurochir (Wien); 2019 Nov; 161(11):2299-2309. PubMed ID: 31478117
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic features of anaplastic myxopapillary ependymomas.
Lee JC; Sharifai N; Dahiya S; Kleinschmidt-DeMasters BK; Rosenblum MK; Reis GF; Samuel D; Siongco AM; Santi M; Storm PB; Ferris SP; Bollen AW; Pekmezci M; Solomon DA; Tihan T; Perry A
Brain Pathol; 2019 Jan; 29(1):75-84. PubMed ID: 30417460
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor.
Yan J; Wu X; Yu J; Yu H; Xu T; Brown KM; Bai X; Dai J; Ma M; Tang H; Si L; Chi Z; Sheng X; Cui C; Kong Y; Guo J
Eur J Cancer; 2018 Jan; 89():90-101. PubMed ID: 29245078
[TBL] [Abstract] [Full Text] [Related]
14. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Wang W; Zhao Z; Wu F; Wang H; Wang J; Lan Q; Zhao J
J Neurooncol; 2018 Feb; 136(3):495-503. PubMed ID: 29168084
[TBL] [Abstract] [Full Text] [Related]
15. [Diagnostic and prognostic roles of loss of CIC protein expression in oligodendroglial tumors].
Liu CC; Zhang LY; Wang LM; Wang DD; Fu YJ; Cai YN; Lu DH; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):679-683. PubMed ID: 29050068
[No Abstract] [Full Text] [Related]
16. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract] [Full Text] [Related]
17. SEMA6A is a prognostic biomarker in glioblastoma.
Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P
Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517
[TBL] [Abstract] [Full Text] [Related]
18. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract] [Full Text] [Related]
19. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
[TBL] [Abstract] [Full Text] [Related]
20. Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.
Kuczma M; Kurczewska A; Kraj P
J Immunotoxicol; 2014 Oct; 11(4):319-27. PubMed ID: 24350726
[TBL] [Abstract] [Full Text] [Related]
[Next]
